FDA Adverse Event Malfunction Summary report: N

THE BELMONT RAPID INFUSER, FMS2000

MDR report key: 3941629 · Received April 15, 2014

Report

Report Number
1219702-2014-00004
Event Type
Malfunction
Date Received
April 15, 2014
Date of Event
March 25, 2014
Report Date
April 15, 2014
Manufacturer
BELMONT INSTRUMENT CORPORATION
Product Code
LGZ
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
MI, US
Reporter Occupation
BIOMEDICAL ENGINEER

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE WAS RETURNED FOR EVALUATION. WE WERE UNABLE TO DUPLICATE THE COMPLAINT UPON RECEIPT; THE UNIT PERFORMED ACCORDING TO OUR SPECIFICATIONS. THE DISPOSABLE SET WAS NOT RETURNED FOR EVALUATION. THE HOSPITAL REPORTED THAT THE ERROR MESSAGE ON THE SCREEN WAS "OVERHEATING". HOWEVER, THE SYSTEM DOES NOT HAVE AN "OVERHEATING" ALARM. THE UNIT MOST LIKELY EXHIBITED EITHER A "POWER MODULE OVERTEMP" ALARM DUE TO BLOCKED FAN AIR VENTS CAUSING THE POWER DRIVER MODULE TO OVERHEAT, OR AN "OVER TEMPERATURE" ALARM DUE TO OVERHEATED INFUSATE, POSSIBLY CAUSED BY DIRTY TEMPERATURE PROBES OR AN OCCLUDED FLOW PATH. BOTH ALARMS WILL CAUSE THE SYSTEM TO SHUT DOWN, AS IT IS DESIGNED TO DO. WHEN THE FMS2000 RECOGNIZES A SITUATION THAT IS COMPROMISING EFFECT INFUSING, IT STOPS PUMPING AND HEATING, STOPS INFUSING FLUID INTO THE PATIENT, DISPLAYS AN ALARM MESSAGE, INSTRUCTIONS FOR CORRECTIVE MEASURE, AND SOUNDS AN AUDIBLE ALARM.

Description of Event or Problem · 1

IT WAS REPORTED BY THE DOCTOR AT (B)(6) THAT DURING A PROCEDURE, THE BELMONT ALARMED AND STOPPED, DISPLAYING AND "OVERHEATING" MESSAGE. A LEAK WAS THEN NOTICED, AND WHEN THE DOOR WAS OPENED THEY FOUND THAT THE DISPOSABLE WAS WARPED AND MELTED. THE MACHINE WAS REPLACED WITH ANOTHER BELMONT AND THE CASE WAS COMPLETED WITHOUT ANY HARM TO THE PATIENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
230290 THE BELMONT RAPID INFUSER, FMS2000 THERMAL INFUSION FLUID WARMER 80 LGZ LGZ BELMONT INSTRUMENT CORPORATION FMS2000 NA

Patients

Seq Age Sex Outcome Treatment
1 UNK